FDA Issues Complete Response Letters to Six Novel Drugs in Q1 2023
According to an analysis, the US FDA issued complete response letters (CRLs) to six novel...
Policy / Regulatory
Henan Province Sees 53.6% Price Reduction in Neuro and Peripheral Intervention Consumables Tender
The Henan Province Public Resources Trading Center has released a notification regarding the completion of...
Indonesia and China Deepen Healthcare Ties with High-Level Dialogue and New Agreements
Indonesia’s deputy minister of health, Dante Saksono Harbuwono, visited China last week as part of...
Shanxi Province Begins Historical Procurement Data Collection for Pacemaker VBP Round
In preparation for a volume-based procurement (VBP) round, Shanxi province has initiated the gathering of...
Fujian Healthcare Security Bureau Updates Sunshine Procurement Mechanism for Drugs
The Fujian Provincial Healthcare Security Bureau has released the Notice on Adjusting and Improving the...
China’s Provincial Governments Implement Second Batch of National Drug Use Monitoring Policy
In line with a notification issued by the National Health Commission (NHC) in January, provincial...
Provincial Budgets Highlight Top Earning Hospitals in China for 2023
Provincial governments have revealed the budget for provincial hospitals’ expected income during 2023, offering a...
Beijing-Tianjin-Hebei Alliance Completes VBP Tender for Coronary Intervention Devices with 78.29% Price Cut
The Beijing-Tianjin-Hebei “3+N” allied region has completed a volume-based procurement (VBP) tender for coronary catheters,...
CDE Launches Guidelines to Expedite Pediatric and Rare Disease Drug Reviews
The Center for Drug Evaluation (CDE) has unveiled a new set of “Work Specifications to...
Round 8 VBP Tender Results Announced with RMB 21.6 Billion Market
The National Allied Procurement Office has issued an initial notification upon the completion of Round...
China’s NHSA Introduces Tiered Pricing for COVID-19 Therapies: A, B, and C Categories
The National Healthcare Security Administration (NHSA) has issued a Notification concerning the improvement of the...
NMPA Introduces Procedures to Adjust Chemical Generic Reference Preparations
The National Medical Products Administration (NMPA) has released a document outlining procedures for the adjustment...
National ADR Monitoring Report Highlights Oncology Drugs and Elderly Patient Safety
The National Center for ADR Monitoring has published its “National Adverse Drug Reaction Monitoring Annual...
China’s New Internet Advertising Regulations Impact Pharmaceutical Sector
The State Administration for Market Regulation has released the latest version of the “Measures for...
CDE Launches Technical Guidelines for Pediatric Anti-tumor Drug Development
The Center for Drug Evaluation (CDE) has released a set of Technical Guidelines focused on...
CDE Issues New Guidance on Pre-Phase III Clinical Trial Meetings for Innovative Drugs
The Center for Drug Evaluation (CDE) has released the “Innovative Chemical Drug Pre-Phase III Clinical...
CDE Launches Technical Guidelines for Pediatric Anti-tumor Drug Clinical R&D
The Center for Drug Evaluation (CDE) has released a set of Technical Guidelines focused on...
CDE Releases Guidance on Pre-Phase III Clinical Trial Meetings for Innovative Chemical Drugs
The Center for Drug Evaluation (CDE) has released the “Innovative Chemical Drug Pre-Phase III Clinical...
China’s Plan to Strengthen Medical and Healthcare Service System Unveiled
The General Office of the CPC Central Committee and State Council has released the “Opinions...
Beijing Initiates Volume-Based Procurement for Ophthalmology and Orthopedics Medical Consumables
The Beijing Municipal Medical Insurance Bureau has released a notification regarding the volume-based procurement (VBP)...